REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q1 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,450 | -19.8% | 29,918 | -2.6% | 0.00% | – |
| Q2 2023 | $614,133 | -9.6% | 30,722 | -14.5% | 0.00% | – |
| Q1 2023 | $679,549 | -9.6% | 35,936 | +8.4% | 0.00% | – |
| Q4 2022 | $751,865 | +142.5% | 33,151 | +182.3% | 0.00% | – |
| Q3 2022 | $310,000 | -67.7% | 11,745 | -59.4% | 0.00% | – |
| Q1 2022 | $959,000 | -33.9% | 28,900 | -34.9% | 0.00% | – |
| Q4 2021 | $1,451,000 | -87.6% | 44,394 | -84.1% | 0.00% | -100.0% |
| Q3 2021 | $11,731,000 | +512.9% | 279,849 | +468.1% | 0.00% | – |
| Q2 2021 | $1,914,000 | +192.2% | 49,259 | +156.5% | 0.00% | – |
| Q1 2021 | $655,000 | -84.4% | 19,203 | -79.3% | 0.00% | -100.0% |
| Q4 2020 | $4,210,000 | +197.1% | 92,795 | +80.3% | 0.00% | +100.0% |
| Q3 2020 | $1,417,000 | +492.9% | 51,479 | +692.0% | 0.00% | – |
| Q2 2020 | $239,000 | +6.2% | 6,500 | +2.8% | 0.00% | – |
| Q3 2019 | $225,000 | -73.1% | 6,320 | -43.0% | 0.00% | -100.0% |
| Q3 2018 | $837,000 | +75.8% | 11,081 | -23.3% | 0.00% | 0.0% |
| Q3 2017 | $476,000 | – | 14,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
| ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
| Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
| WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
| Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
| Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
| Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
| Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |